Dermira (DERM) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts DERM Hot Sheet
Join SI Premium – FREE
Dermira (NASDAQ: DERM) reported Q3 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.6 million versus the consensus estimate of $18.66 million.
For earnings history and earnings-related data on Dermira (DERM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
- Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming
- Western Midstream prices $700M in senior notes due 2036
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
